![Dana Hilt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 974 000 $ in data 30/09/2026
Dr. Dana C.
Hilt, MD, is a Chief Medical Officer at Actinogen Medical Ltd. Dr. Hilt was previously employed as a Chief Medical Officer by Frequency Therapeutics, Inc., a Chief Medical Officer by Lysosomal Therapeutics, Inc., a Chief Medical Officer by Critical Therapeutics, Inc., a Chief Medical Officer & SVP-Drug Development by FORUM Pharmaceuticals, Inc., a Director-Clinical Neurosciences by Amgen, Inc., a Chief Medical Officer by Ascend Pharmaceuticals, Inc., a Chief Medical Officer & SVP-Clinical Research by ASCEND Therapeutics US LLC, a Chief Medical Officer by Brenig Therapeutics, Inc., and a Vice President-Clinical Research by Guilford Pharmaceuticals, Inc. He received his undergraduate degree from the University of Maine and a doctorate degree from Tufts University School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/08/2025 | 25.000.000 ( 0,65% ) | 974 000 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Direttore Tecnico/Scientifico/R&S | 01/02/2023 |
| Società | Posizione | Fine |
|---|---|---|
Brenig Therapeutics, Inc.
 Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Direttore Tecnico/Scientifico/R&S | 10/06/2025 |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Direttore Tecnico/Scientifico/R&S | 01/08/2019 |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Direttore Tecnico/Scientifico/R&S | 25/09/2007 |
ASCEND Therapeutics US LLC
 ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Direttore Tecnico/Scientifico/R&S | - |
| KORRO BIO, INC. | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
University of Maine
 University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinogen Medical Ltd.
 Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
Ascend Pharmaceuticals, Inc. | |
ASCEND Therapeutics US LLC
ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
